» Articles » PMID: 33995306

Repulsive Guidance Molecule B Deficiency Induces Gut Microbiota Dysbiosis and Increases the Susceptibility to Intestinal Inflammation in Mice

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2021 May 17
PMID 33995306
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Imbalance of gut microbiota can induce or aggravate intestinal inflammation. To enhance our understanding of the molecular mechanisms of gut microbiota and inflammatory bowel disease (IBD), we studied the role of repulsive guidance molecule b (RGMb) in gut microbiota and colitis in mice. We generated Rgmb knockout mice and inducible Rgmb knockout mice and induced colitis using dextran sulfate sodium (DSS) in these mice. 16S ribosomal RNA (rRNA) high-throughput sequencing was performed to acquire the gut microbiota composition and abundance. We found that Rgmb deficiency significantly altered the diversity of gut microbiota and also induced dysbiosis. In sharp contrast to the balanced distribution of various bacteria in control mice, was almost exhausted in Rgmb-deficient mice under both basal and inflammatory conditions. Correlation analysis indicated that was negatively associated with inflammation in Rgmb-deficient mice with colitis. Similar results were obtained at the early inflammatory stage of colitis associated colon cancer (CAC). Taken together, our results reveal that Rgmb deficiency leads to dysbiosis of predominant gut microbiota under basal and inflammatory conditions. Rgmb-deficiency-mediated loss may render mice more susceptible to intestinal inflammation. Therefore, RGMb may be a novel potential target for reconstruction of the gut microbiota for the treatment of IBD.

Citing Articles

Interplay of Transcriptomic Regulation, Microbiota, and Signaling Pathways in Lung and Gut Inflammation-Induced Tumorigenesis.

Otalora-Otalora B, Payan-Gomez C, Lopez-Rivera J, Pedroza-Aconcha N, Arboleda-Mojica S, Aristizabal-Guzman C Cells. 2025; 14(1.

PMID: 39791702 PMC: 11720097. DOI: 10.3390/cells14010001.


Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses.

Cao M, Cui B Cardiovasc Diabetol. 2024; 23(1):126.

PMID: 38614964 PMC: 11016216. DOI: 10.1186/s12933-024-02222-1.


The B7:CD28 family and friends: Unraveling coinhibitory interactions.

Burke K, Chaudhri A, Freeman G, Sharpe A Immunity. 2024; 57(2):223-244.

PMID: 38354702 PMC: 10889489. DOI: 10.1016/j.immuni.2024.01.013.


Cultured Extract and subsp. (Canan SV-53) Intake Alleviates Immune Deregulation and Inflammation by Modulating Signaling Pathways and Epigenetic Mechanisms.

Shahbazi R, Yasavoli-Sharahi H, Alsadi N, Sharifzad F, Fang S, Cuenin C Int J Mol Sci. 2023; 24(19).

PMID: 37834058 PMC: 10572597. DOI: 10.3390/ijms241914610.


Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance.

Park J, Gazzaniga F, Wu M, Luthens A, Gillis J, Zheng W Nature. 2023; 617(7960):377-385.

PMID: 37138075 PMC: 10219577. DOI: 10.1038/s41586-023-06026-3.


References
1.
Levy R, Magis A, Earls J, Manor O, Wilmanski T, Lovejoy J . Longitudinal analysis reveals transition barriers between dominant ecological states in the gut microbiome. Proc Natl Acad Sci U S A. 2020; 117(24):13839-13845. PMC: 7306764. DOI: 10.1073/pnas.1922498117. View

2.
Shi Y, Huang X, Chen G, Wang Y, Zhi Q, Liu Y . Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells. Oncotarget. 2016; 7(30):48027-48037. PMC: 5216997. DOI: 10.18632/oncotarget.10338. View

3.
Aviello G, Singh A, ONeill S, Conroy E, Gallagher W, DAgostino G . Colitis susceptibility in mice with reactive oxygen species deficiency is mediated by mucus barrier and immune defense defects. Mucosal Immunol. 2019; 12(6):1316-1326. DOI: 10.1038/s41385-019-0205-x. View

4.
Liu W, Chen B, Wang Y, Meng C, Huang H, Huang X . RGMb protects against acute kidney injury by inhibiting tubular cell necroptosis via an MLKL-dependent mechanism. Proc Natl Acad Sci U S A. 2018; 115(7):E1475-E1484. PMC: 5816182. DOI: 10.1073/pnas.1716959115. View

5.
Chen L, Wang W, Zhou R, Ng S, Li J, Huang M . Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease. Medicine (Baltimore). 2014; 93(8):e51. PMC: 4602441. DOI: 10.1097/MD.0000000000000051. View